4,378
Views
71
CrossRef citations to date
0
Altmetric
Original Research

D-2-hydroxyglutarate interferes with HIF-1α stability skewing T-cell metabolism towards oxidative phosphorylation and impairing Th17 polarization

ORCID Icon, , , , ORCID Icon, , , , , & show all
Article: e1445454 | Received 15 Dec 2017, Accepted 21 Feb 2018, Published online: 26 Mar 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Leland G. Richardson, Linda T. Nieman, Anat O. Stemmer-Rachamimov, Xijin S. Zheng, Khalifa Stafford, Hiroaki Nagashima, Julie J. Miller, Juri Kiyokawa, David T. Ting, Hiroaki Wakimoto, Daniel P. Cahill, Bryan D. Choi & William T. Curry. (2020) IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice. OncoImmunology 9:1.
Read now
Lorenzo Galluzzi & Guido Kroemer. (2018) Potent immunosuppressive effects of the oncometabolite R-2-hydroxyglutarate. OncoImmunology 7:12.
Read now

Articles from other publishers (69)

Lukas Häselbarth, Sara Gamali, Domenica Saul, Manuela Krumbholz, Romy Böttcher-Loschinski, Martin Böttcher, Deyu Zou, Markus Metzler, Axel Karow & Dimitrios Mougiakakos. (2023) Synergistic lethality in chronic myeloid leukemia – targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment. BMC Cancer 23:1.
Crossref
Kotohiko Kimura, Tiffany L. B. Jackson & Ru Chih C. Huang. (2023) Interaction and Collaboration of SP1, HIF-1, and MYC in Regulating the Expression of Cancer-Related Genes to Further Enhance Anticancer Drug Development. Current Issues in Molecular Biology 45:11, pages 9262-9283.
Crossref
Iosifina P Foskolou, Lukas Bunse & Jan Van den Bossche. (2023) 2-hydroxyglutarate rides the cancer-immunity cycle. Current Opinion in Biotechnology 83, pages 102976.
Crossref
Iosifina P. Foskolou, Pedro P. Cunha, Elena Sánchez-López, Eleanor A. Minogue, Benoît P. Nicolet, Aurélie Guislain, Christian Jorgensen, Sarantos Kostidis, Nordin D. Zandhuis, Laura Barbieri, David Bargiela, Demitris Nathanael, Petros A. Tyrakis, Asis Palazon, Martin Giera, Monika C. Wolkers & Randall S. Johnson. (2023) The two enantiomers of 2-hydroxyglutarate differentially regulate cytotoxic T cell function. Cell Reports 42:9, pages 113013.
Crossref
Chun Zhang, Jing Xiao, Luzhong Fa, Fanwen Jiang, Hui Jiang, Lin Zhou & Zhuping Xu. (2023) Identification of co-expressed gene networks promoting CD8+ T cell infiltration and having prognostic value in uveal melanoma. BMC Ophthalmology 23:1.
Crossref
Daniela Damiani & Mario Tiribelli. (2023) Checkpoint Inhibitors in Acute Myeloid Leukemia. Biomedicines 11:6, pages 1724.
Crossref
Dhana Sekhar Reddy Bandi, Sujith Sarvesh, Batoul Farran, Ganji Purnachandra Nagaraju & Bassel F. El-Rayes. (2023) Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions. Cytokine & Growth Factor Reviews.
Crossref
Lukas Häselbarth, Axel Karow, Kristin Mentz, Martin Böttcher, Oisin Roche-Lancaster, Manuela Krumbholz, Regina Jitschin, Dimitrios Mougiakakos & Markus Metzler. (2023) Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib. Cancer Immunology, Immunotherapy 72:6, pages 1661-1672.
Crossref
Yu-Ting Zhang, Mu-Lan Xing, Hui-Hua Fang, Wei-Dong Li, Li Wu & Zhi-Peng Chen. (2023) Effects of lactate on metabolism and differentiation of CD4+T cells. Molecular Immunology 154, pages 96-107.
Crossref
Brandon L. McClellan, Santiago Haase, Felipe J. Nunez, Mahmoud S. Alghamri, Ali A. Dabaja, Pedro R. Lowenstein & Maria G. Castro. (2023) Impact of epigenetic reprogramming on antitumor immune responses in glioma. Journal of Clinical Investigation 133:2.
Crossref
Xin Lian, Kailin Yang, Renliang Li, Maomao Li, Jing Zuo, Bohao Zheng, Wei Wang, Ping Wang & Shengtao Zhou. (2022) Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy. Molecular Cancer 21:1.
Crossref
Samaneh Mostafavi, Hamidreza Zalpoor & Zuhair Mohammad Hassan. (2022) The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors. Cellular & Molecular Biology Letters 27:1.
Crossref
Quentin Richard, Alice Laurenge, Michel Mallat, Marc Sanson & Luis Jaime Castro-Vega. (2022) New insights into the Immune TME of adult-type diffuse gliomas. Current Opinion in Neurology 35:6, pages 794-802.
Crossref
Yingqian Ni, Peibo Shen, Xingchen Wang, He Liu, Huiyuan Luo & Xiuzhen Han. (2022) The roles of IDH1 in tumor metabolism and immunity. Future Oncology 18:35, pages 3941-3953.
Crossref
Sayan Chakraborty, Poulomi Khamaru & Arindam Bhattacharyya. (2022) Regulation of immune cell metabolism in health and disease: Special focus on T and B cell subsets. Cell Biology International 46:11, pages 1729-1746.
Crossref
Emma van Kessel, Sharon Berendsen, Anniek E Baumfalk, Hema Venugopal, Eva A Krijnen, Wim G M Spliet, Wim van Hecke, Fabrizio Giuliani, Tatjana Seute, Martine J E van Zandvoort, Tom J Snijders & Pierre A Robe. (2022) Tumor-related molecular determinants of neurocognitive deficits in patients with diffuse glioma. Neuro-Oncology 24:10, pages 1660-1670.
Crossref
Julie J. Miller. (2022) Targeting IDH-Mutant Glioma. Neurotherapeutics 19:6, pages 1724-1732.
Crossref
Armin Mortazavi, Islam Fayed, Muzna Bachani, Tyrone Dowdy, Jahandar Jahanipour, Anas Khan, Jemima Owotade, Stuart Walbridge, Sara K Inati, Joseph Steiner, Jing Wu, Mark Gilbert, Chun Zhang Yang, Mioara Larion, Dragan Maric, Alexander Ksendzovsky & Kareem A Zaghloul. (2022) IDH-mutated gliomas promote epileptogenesis through d -2-hydroxyglutarate-dependent mTOR hyperactivation . Neuro-Oncology 24:9, pages 1423-1435.
Crossref
Yuheng Yan, Lan Huang, Yiming Liu, Ming Yi, Qian Chu, Dechao Jiao & Kongming Wu. (2022) Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity. Journal of Hematology & Oncology 15:1.
Crossref
Alexandra Wagner, Helena Kosnacova, Miroslav Chovanec & Dana Jurkovicova. (2022) Mitochondrial Genetic and Epigenetic Regulations in Cancer: Therapeutic Potential. International Journal of Molecular Sciences 23:14, pages 7897.
Crossref
Martin Böttcher, Romy Böttcher-Loschinski, Sascha Kahlfuss, Michael Aigner, Andreas Gießl, Andreas Mackensen, Ursula Schlötzer-Schrehardt, Thomas Tüting, Heiko Bruns & Dimitrios Mougiakakos. (2022) CLL-Derived Extracellular Vesicles Impair T-Cell Activation and Foster T-Cell Exhaustion via Multiple Immunological Checkpoints. Cells 11:14, pages 2176.
Crossref
Prateek Agarwal, Oliver M. Beale, Xiaoran Zhang, Poorva Sandlesh, Emade Jaman & Nduka Amankulor. (2022) Machine Learning Identification of Immunotherapy Targets in Low-Grade Glioma Using RNA Sequencing Expression Data. World Neurosurgery 163, pages e349-e362.
Crossref
Dongming Yan, Weicheng Li, Qibing Liu & Kun Yang. (2022) Advances in Immune Microenvironment and Immunotherapy of Isocitrate Dehydrogenase Mutated Glioma. Frontiers in Immunology 13.
Crossref
Vittoria Raimondi, Giulia Ciotti, Michele Gottardi & Francesco Ciccarese. (2022) 2-Hydroxyglutarate in Acute Myeloid Leukemia: A Journey from Pathogenesis to Therapies. Biomedicines 10:6, pages 1359.
Crossref
Mariam Markouli, Dimitrios Strepkos, Kostas A. Papavassiliou, Athanasios G. Papavassiliou & Christina Piperi. (2022) Crosstalk of Epigenetic and Metabolic Signaling Underpinning Glioblastoma Pathogenesis. Cancers 14:11, pages 2655.
Crossref
Thibault Comont, Marie-Laure Nicolau-Travers, Sarah Bertoli, Christian Recher, Francois Vergez & Emmanuel Treiner. (2021) MAIT cells numbers and frequencies in patients with acute myeloid leukemia at diagnosis: association with cytogenetic profile and gene mutations. Cancer Immunology, Immunotherapy 71:4, pages 875-887.
Crossref
Jonas Aakre Wik & Bjørn Steen Skålhegg. (2022) T Cell Metabolism in Infection. Frontiers in Immunology 13.
Crossref
Robert P. Ostrowski & Emanuela B. Pucko. (2022) Harnessing oxidative stress for anti-glioma therapy. Neurochemistry International 154, pages 105281.
Crossref
Dean Amir, Adi Hendler‐Neumark, Verena Wulf, Roni Ehrlich & Gili Bisker. (2021) Oncometabolite Fingerprinting Using Fluorescent Single‐Walled Carbon Nanotubes. Advanced Materials Interfaces 9:4.
Crossref
Omar Domínguez-Amorocho, Gonzalo Soto-Heredero & María Mittelbrunn. 2022. Essential Aspects of Immunometabolism in Health and Disease. Essential Aspects of Immunometabolism in Health and Disease 115 132 .
Niamh C. Williams, Dylan G. Ryan, Ana S.H. Costa, Evanna L. Mills, Mark P. Jedrychowski, Suzanne M. Cloonan, Christian Frezza & Luke A. O’Neill. (2021) Signalling metabolite L-2-hydroxyglutarate activates the transcription factor HIF-1α in lipopolysaccharide-activated macrophages. Journal of Biological Chemistry, pages 101501.
Crossref
Ramsey Bekdash, Jose R. Quejada, Shunnosuke Ueno, Fuun Kawano, Kumi Morikawa, Alison D. Klein, Kenji Matsumoto, Tetz C. Lee, Koki Nakanishi, Amy Chalan, Teresa M. Lee, Rui Liu, Shunichi Homma, Chyuan-Sheng Lin, Maria V. Yelshanskaya, Alexander I. Sobolevsky, Keisuke Goda & Masayuki Yazawa. (2021) GEM-IL: A highly responsive fluorescent lactate indicator. Cell Reports Methods 1:7, pages 100092.
Crossref
Shen-Han Lee, Monika Golinska & John R. Griffiths. (2021) HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells. Cells 10:9, pages 2371.
Crossref
Francesco Tarantini, Cosimo Cumbo, Luisa Anelli, Antonella Zagaria, Giorgina Specchia, Pellegrino Musto & Francesco Albano. (2021) Can the New and Old Drugs Exert an Immunomodulatory Effect in Acute Myeloid Leukemia?. Cancers 13:16, pages 4121.
Crossref
Lin Xiao, Harrison Yeung, Michelle Haber, Murray D. Norris & Klaartje Somers. (2021) Immunometabolism: A ‘Hot’ Switch for ‘Cold’ Pediatric Solid Tumors. Trends in Cancer 7:8, pages 751-777.
Crossref
M. Platten, L. Bunse & W. Wick. (2021) Emerging targets for anticancer vaccination: IDH. ESMO Open 6:4, pages 100214.
Crossref
Emanuela Di Gregorio, Gianmaria Miolo, Asia Saorin, Agostino Steffan & Giuseppe Corona. (2021) From Metabolism to Genetics and Vice Versa: The Rising Role of Oncometabolites in Cancer Development and Therapy. International Journal of Molecular Sciences 22:11, pages 5574.
Crossref
Joseph Eniafe & Shuai Jiang. (2021) The functional roles of TCA cycle metabolites in cancer. Oncogene 40:19, pages 3351-3363.
Crossref
Marike W. van Gisbergen, Emma Zwilling & Ludwig J. Dubois. (2021) Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio. Frontiers in Oncology 11.
Crossref
Jasna Friščić, Martin Böttcher, Christiane Reinwald, Heiko Bruns, Benjamin Wirth, Samantha-Josefine Popp, Kellie Irene Walker, Jochen A. Ackermann, Xi Chen, Jason Turner, Honglin Zhu, Lisa Seyler, Maximilien Euler, Philipp Kirchner, René Krüger, Arif B. Ekici, Triin Major, Oliver Aust, Daniela Weidner, Anita Fischer, Fabian T. Andes, Zeljka Stanojevic, Vladimir Trajkovic, Martin Herrmann, Adelheid Korb-Pap, Isabel Wank, Andreas Hess, Johnathan Winter, Viktor Wixler, Jörg Distler, Günter Steiner, Hans P. Kiener, Benjamin Frey, Lasse Kling, Karim Raza, Silke Frey, Arnd Kleyer, Tobias Bäuerle, Timothy R. Hughes, Anika Grüneboom, Ulrike Steffen, Gerhard Krönke, Adam P. Croft, Andrew Filer, Jörg Köhl, Kerstin Klein, Christopher D. Buckley, Georg Schett, Dimitrios Mougiakakos & Markus H. Hoffmann. (2021) The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts. Immunity 54:5, pages 1002-1021.e10.
Crossref
Raffaela S. Berger, Christian J. Wachsmuth, Magdalena C. Waldhier, Kathrin Renner-Sattler, Simone Thomas, Anuhar Chaturvedi, Hans-Helmut Niller, Elisabeth Bumes, Peter Hau, Martin Proescholdt, Wolfram Gronwald, Michael Heuser, Marina Kreutz, Peter J. Oefner & Katja Dettmer. (2021) Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous Metabolite. Cancers 13:8, pages 1756.
Crossref
Julie Leca, Jerome Fortin & Tak W Mak. (2021) Illuminating the cross-talk between tumor metabolism and immunity in IDH-mutated cancers. Current Opinion in Biotechnology 68, pages 181-185.
Crossref
Xin Du & Hai Hu. (2021) The Roles of 2-Hydroxyglutarate. Frontiers in Cell and Developmental Biology 9.
Crossref
Amrita Chaudhary, Swarnendu Bag, Neeraj Arora, Vivek S. Radhakrishnan, Deepak Mishra & Geetashree Mukherjee. (2020) Hypoxic Transformation of Immune Cell Metabolism Within the Microenvironment of Oral Cancers. Frontiers in Oral Health 1.
Crossref
Ping-Chang Kuo, Wen-Tsan Weng, Barbara A. Scofield, Hallel C. Paraiso, Dennis A. Brown, Pei-Yu Wang, I-Chen Yu & Jui-Hung Yen. (2020) Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis. Journal of Neuroinflammation 17:1.
Crossref
Julie-Aurore Losman, Peppi Koivunen & William G. KaelinJr.Jr.. (2020) 2-Oxoglutarate-dependent dioxygenases in cancer. Nature Reviews Cancer 20:12, pages 710-726.
Crossref
Shrikant S. Kolan, Gaoyang Li, Jonas A. Wik, Giulia Malachin, Shuai Guo, Pratibha Kolan & Bjørn S. Skålhegg. (2020) Cellular metabolism dictates T cell effector function in health and disease. Scandinavian Journal of Immunology 92:5.
Crossref
Petr Ježek. (2020) 2-Hydroxyglutarate in Cancer Cells. Antioxidants & Redox Signaling 33:13, pages 903-926.
Crossref
Benedikt Jacobs, Sebastian Schlögl, Carolin Dorothea Strobl, Simon Völkl, Andrej Stoll, Dimitrios Mougiakakos, Karl-Johan Malmberg, Andreas Mackensen & Michael Aigner. (2020) The Oncometabolite 5′-Deoxy-5′-Methylthioadenosine Blocks Multiple Signaling Pathways of NK Cell Activation. Frontiers in Immunology 11.
Crossref
Eline Constance Brombacher & Bart Everts. (2020) Shaping of Dendritic Cell Function by the Metabolic Micro-Environment. Frontiers in Endocrinology 11.
Crossref
Maria-Paz Garcia-CuellarJennifer LawlorMartin Böttcher, Dimitrios Mougiakakos, Markus Metzler & Robert K. Slany. (2020) Exploitable metabolic dependencies in MLL-ENL–induced leukemia. Blood Advances 4:15, pages 3626-3638.
Crossref
Gonzalo Soto‐Heredero, Manuel M. Gómez de las Heras, Enrique Gabandé‐Rodríguez, Jorge Oller & María Mittelbrunn. (2020) Glycolysis – a key player in the inflammatory response. The FEBS Journal 287:16, pages 3350-3369.
Crossref
Peter J. Siska, Katrin Singer, Katja Evert, Kathrin Renner & Marina Kreutz. (2020) The immunological Warburg effect: Can a metabolic‐tumor‐stroma score (MeTS) guide cancer immunotherapy?. Immunological Reviews 295:1, pages 187-202.
Crossref
R. Rezaei, S. Tahmasebi, Mohammad R. Atashzar & D. Amani. (2020) Glycolysis and Autoimmune Diseases: A Growing Relationship. Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology 14:2, pages 91-106.
Crossref
Susan F. Fitzpatrick, Simon Lambden, David Macias, Zudin Puthucheary, Sandra Pietsch, Lee Mendil, Mark J. W. McPhail & Randall S. Johnson. (2020) 2-Hydroxyglutarate Metabolism Is Altered in an in vivo Model of LPS Induced Endotoxemia. Frontiers in Physiology 11.
Crossref
Carolin Dorothea Strobl, Stefanie Schaffer, Tabea Haug, Simon Völkl, Katrin Peter, Katrin Singer, Martin Böttcher, Dimitrios Mougiakakos, Andreas Mackensen & Michael Aigner. (2020) Selective PRMT5 Inhibitors Suppress Human CD8+ T Cells by Upregulation of p53 and Impairment of the AKT Pathway Similar to the Tumor Metabolite MTA. Molecular Cancer Therapeutics 19:2, pages 409-419.
Crossref
Ovidiu C. Andronesi, Tracy T. Batchelor & Daniel P. Cahill. 2020. Glioma Imaging. Glioma Imaging 173 189 .
Lourdes M. Mendez, Ryan R. Posey & Pier Paolo Pandolfi. (2019) The Interplay Between the Genetic and Immune Landscapes of AML: Mechanisms and Implications for Risk Stratification and Therapy. Frontiers in Oncology 9.
Crossref
Dimitrios Mougiakakos. (2019) The Induction of a Permissive Environment to Promote T Cell Immune Evasion in Acute Myeloid Leukemia: The Metabolic Perspective. Frontiers in Oncology 9.
Crossref
Jong-Whi Park & Şevin Turcan. (2019) Epigenetic Reprogramming for Targeting IDH-Mutant Malignant Gliomas. Cancers 11:10, pages 1616.
Crossref
Chao-jun Han, Ji-yue Zheng, Lin Sun, Hui-cui Yang, Zhong-qiang Cao, Xiao-hu Zhang, Long-tai Zheng & Xue-chu Zhen. (2019) The oncometabolite 2-hydroxyglutarate inhibits microglial activation via the AMPK/mTOR/NF-κB pathway. Acta Pharmacologica Sinica 40:10, pages 1292-1302.
Crossref
Sheng-Li Liu, Yan-Man Zhou, Da-Bin Tang, Neng Zhou, Wei-Wei Zheng, Zhong-Hua Tang, Cai-Wen Duan & Jing Chen. (2019) Rapamycin ameliorates immune-mediated aplastic anemia by inhibiting the proliferation and metabolism of T cells. Biochemical and Biophysical Research Communications 518:2, pages 212-218.
Crossref
Raffaela S. Berger, Lisa Ellmann, Joerg Reinders, Marina Kreutz, Thomas Stempfl, Peter J. Oefner & Katja Dettmer. (2019) Degradation of D-2-hydroxyglutarate in the presence of isocitrate dehydrogenase mutations. Scientific Reports 9:1.
Crossref
Hongxing Shen & Lewis Zhichang Shi. (2019) Metabolic regulation of TH17 cells. Molecular Immunology 109, pages 81-87.
Crossref
Tabea Haug, Michael Aigner, Moritz M. Peuser, Carolin D. Strobl, Kai Hildner, Dimitrios Mougiakakos, Heiko Bruns, Andreas Mackensen & Simon Völkl. (2019) Human Double-Negative Regulatory T-Cells Induce a Metabolic and Functional Switch in Effector T-Cells by Suppressing mTOR Activity. Frontiers in Immunology 10.
Crossref
Ines Ugele, Zugey Cárdenas-Conejo, Kathrin Hammon, Monika Wehrstein, Christina Bruss, Katrin Peter, Katrin Singer, Eva Gottfried, Jakob Boesch, Peter Oefner, Katja Dettmer, Kathrin Renner & Marina Kreutz. (2019) D-2-Hydroxyglutarate and L-2-Hydroxyglutarate Inhibit IL-12 Secretion by Human Monocyte-Derived Dendritic Cells. International Journal of Molecular Sciences 20:3, pages 742.
Crossref
. (2019) Immunometabolic Regulation of Anti-Tumor T-Cell Responses by the Oncometabolite D-2-Hydroxyglutarate. Immunometabolism.
Crossref
Ann M. Joseph, Laurel A. Monticelli & Gregory F. Sonnenberg. (2018) Metabolic regulation of innate and adaptive lymphocyte effector responses. Immunological Reviews 286:1, pages 137-147.
Crossref
Mirco Friedrich, Lukas Bunse, Wolfgang WickMichael Platten. (2018) Perspectives of immunotherapy in isocitrate dehydrogenase-mutant gliomas. Current Opinion in Oncology 30:6, pages 368-374.
Crossref